lobbying_activities: 2638968

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2638968	a503a92b-c3b6-4120-a695-203ecc4fef45	Q2	SAM ACTION, INC.	401104337	SAM ACTION, INC.	2021	second_quarter	CSP	Safety issues surrounding marijuana, marketing of high potency marijuana products to children.	Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),Office of Natl Drug Control Policy (NDCP),SENATE,Small Business Administration (SBA),White House Office		10000	0	0	2021-07-16T08:20:32.723000-04:00